2017 edition
The 2017 edition of the Rhinology Future Debates was held on 8 December 2017, in Brussels, Belgium. The following sessions were discussed between Industry representatives, patients representatives and expert panelists.
- Debate I
Real World Evidence data in AIT - what does it bring to us?
Panellists: Jean Bousquet, Claus Bachert, Peter Hellings, Oliver Pfaar, David Price, Glenis Scadding, & Emmanuel Prokopakis
- Debate II
Positioning Dymista in allergic rhinitis treatment
Panellists: David Price, Glenis Scadding, Claus Bachert, Peter Hellings, Wytske Fokkens, Emmanuel Prokopakis, Oliver Pfaar, Jean Bousquet, & Patient representative
- Debate III
Nasal turbinate as therapeutic target
Panellists: Glenis Scadding, Claus Bachert, Peter Hellings, Wytske Fokkens, Emmanuel Prokopakis, & Patient representatives
- Debate IV
Lessons from biologicals in asthma for ENT
Panellists: Peter Hellings, Claus Bachert, Guy Joos, Renaud Louis. Charles Pilette, David Price, Glenis Scadding, Wytske Fokkens, & Patient representatives
Impressions of the 2017 edition
Debate II 2017
Debate III 2017
Debate IV 2017
They dare going to uncharted waters in the discussion, and I think this is a really good learning experience for everybody
Anders Weilandt - Chordate Medical
Partners of the 2017 Rhinology Future Debates
Stallergenes Greer, Mylan, Chordate, Medtronic, Sanofi & AstraZeneca
Special thanks to BMW Brussels for their logistical support
More info
If you would like to propose a topic, learn about the partnership opportunities, the programme of the next editions, or any other enquiries regarding the Respiratory Future Debates, please contact us.